简介 联系方式 相互作用: 118 620
根据名称进行药物检索

Acetaminophen, Aspirin, Caffeine, and Salicylamide Tablets与凝结

Acetaminophen, Aspirin, Caffeine, and Salicylamide Tablets与凝结安全配伍检测的结果。

检测结果:
Acetaminophen, Aspirin, Caffeine, and Salicylamide Tablets <> 凝结
现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com,在进行所选药物与这种伴发疾病互相作用检测时,发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

使用阿司匹林是禁忌,在患者与重大活动出血或血性疾病,如血友病、血友病的疾病,或者毛细血管扩张症。 阿司匹林干扰了凝固的不可逆转抑制血小板聚集和延长流血的时间。 非乙酰化水杨酸(即水杨酸盐如钠或水杨酸镁)未表明这些影响和可能是适当的替代在这些患者。 然而,所有水杨酸盐能干扰行动的维生素K和诱导剂量依赖性的改变,肝脏合成的混凝因素七、九和十.在通常的推荐剂量略有增加凝血酶原时间(PT)可能会发生。 治疗与水杨酸,特别是阿司匹林,应当给予极为谨慎,在患者与低凝血酶原血症、维生素K缺乏症、血小板减少、血栓形成的血小板减少性紫癜,严重的肝损伤,或者抗凝血剂使用。

来源
  • Buerke M, Pittroff W, Meyer J, Darius H "Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses." Am Heart J 130 (1995): 465-72
  • Ferraris VA, Ferraris SP "Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting - update." Ann Thorac Surg 59 (1995): 1036-7
  • "Product Information. Ecotrin (aspirin)." SmithKline Beecham, Philadelphia, PA.
  • Patrono C "Aspirin as an antiplatelet drug." N Engl J Med 330 (1994): 1287-94
  • Garg SK, Sarker CR "Aspirin-induced thrombocytopenia on an immune basis." Am J Med Sci 267 (1974): 129-32
  • "Product Information. Bayer aspirin (aspirin)." Bayer, West Haven, CT.
  • Bochner F, Williams DB, Morris PM, Siebert DM, Lloyd JV "Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function." Eur J Clin Pharmacol 35 (1988): 287-94
  • Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G "Aspirin and other platelet-active drugs: the relationship among dose, effectiveness, and side effects." Chest 108 Suppl (1995): s247-57
  • Colwell JA "Aspirin and risk of hemorrhagic stroke." JAMA 282 (1999): 731-2
  • Petty GW, Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO "Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention: a population study." Ann Intern Med 130 (1999): 14-22
  • He J, Whelton PK, Vu B, Klag MJ "Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials." JAMA 280 (1998): 1930-35
  • Moroz LA "Increased blood fibrinolytic activity after aspirin ingestion." N Engl J Med 296 (1977): 525-9
  • Sbarbaro JA, Bennett RM "Aspirin hepatotoxicity and disseminated intravascular coagulation." Ann Intern Med 86 (1977): 183-5
  • American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):
Acetaminophen, Aspirin, Caffeine, and Salicylamide Tablets

非专利名称: acetaminophen / aspirin / caffeine / salicylamide

品牌: Levacet, Painaid

同义词:

Acetaminophen, Aspirin, Caffeine, and Salicylamide Tablets <> 凝结
现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com,在进行所选药物与这种伴发疾病互相作用检测时,发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

所有水杨酸盐能干扰行动的维生素K和诱导剂量依赖性的改变,肝脏合成的混凝因素七、九和十.在通常的推荐剂量略有增加凝血酶原时间(PT)可能会发生。 治疗与水杨酸,特别是如果给予在高剂量时,应给予谨慎的患者的重大活动出血或一个出血性素质,其中包括止血和/或凝固的缺陷,与血友病、维生素K缺乏,低血栓蛋白血症、血小板减少、血小板,或严重的肝功能损害。 同样的预防措施应当也能观察到的与使用有关代理诸如水杨酰胺,因为它们的结构和药理类似水杨酸盐。

来源
  • Fausa O "Salicylate-induced hypoprothrombinemia: a report of four cases." Acta Med Scand 188 (1970): 403-8
  • "Product Information. Pepto-Bismol (bismuth subsalicylate)." Procter and Gamble Pharmaceuticals, Cincinnati, OH.
  • American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):
  • "Product Information. Salflex (salsalate)." Carnrick Laboratories Inc, Cedar Knolls, NJ.
  • Barrow MV, Quick DT, Cunningham RW "Salicylate hypoprothrombinemia in rheumatoid arthritis with liver disease. Report of two cases." Arch Intern Med 120 (1967): 620-4
Acetaminophen, Aspirin, Caffeine, and Salicylamide Tablets

非专利名称: acetaminophen / aspirin / caffeine / salicylamide

品牌: Levacet, Painaid

同义词: